Rare Thyroid Therapeutics is a privately held pharmaceutical company, developing therapies for rare and neglected thyroid hormone disorders. Our lead product candidate Emcitate® is under development for the treatment of MCT8 deficiency, also called Allan-Herndon-Dudley Syndrome, a rare inborn X-linked disorder caused by a dysfunctional thyroid hormone transporter.
,
Founded in 2017
Myself Only employees
Rare Thyroid Therapeutics is a privately held pharmaceutical company, developing therapies for rare and neglected thyroid hormone disorders. Our lead product candidate Emcitate® is under development for the treatment of MCT8 deficiency, also called Allan-Herndon-Dudley Syndrome, a rare inborn X-linked disorder caused by a dysfunctional thyroid hormone transporter.
Company Information
- Industry
- Company Type
- Privately Held
- Founded
- 2017
- Employee Range
- Myself Only
- Revenue Range
- Not available
Location
- Address
- Teatergatan 3 Stockholm County Stockholm
- City
- Region
- Postal Code
- 111 48
- Country
- Sweden
Web Presence
Websiterarethyroid.com
LinkedIn0 followers